MedTrace Logo

The REgistry of Very Early Estrogen and AnovuLation

NCT06583408 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2025-11-21

No results posted yet for this study

Summary

The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.

Conditions

  • Hypothalamic Amenorrhea, Functional
  • Hypothalamic Amenorrhea
  • Functional Hypogonadotropic Hypogonadism

Interventions

OTHER

Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24)

Subjects will complete the ASA food diary for 2 weekdays and 1 weekend day

OTHER

REVEAL Questionnaire

Subjects will complete the REVEAL questionnaire form. This form includes questions about current and past medical history, including reproductive history, lifestyle specifics, and assessment of current health status.

Sponsors & Collaborators

Principal Investigators

  • Chrisandra Shufelt, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2029-08-01
Completion
2029-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06583408 on ClinicalTrials.gov